TNF and rheumatoid arthritis: In this study, the genetic tools available to E. coli were utilized to engineer synthetic eukaryotic redox pathway and evaluate its effect on the production of the most profitable and widely used therapeutic antibody Humira (adalimumab) against human tumor necrosis factor alpha (TNFα), used as a blocker to treat rheumatoid arthritis (Scheinfeld 2003).